Indaptus Therapeutics, Inc. has filed 324 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| DEF 14A | 2026-07-16 | Proxy Statement |
| S-3 | 2026-06-26 | Registration Statement (Shelf) |
| SC 13D/A | 2026-06-26 | Beneficial Ownership Report (Amended) |
| SC 13D/A | 2026-06-26 | Beneficial Ownership Report (Amended) |
| SC 13D/A | 2026-06-26 | Beneficial Ownership Report (Amended) |
| SC 13D/A | 2026-06-26 | Beneficial Ownership Report (Amended) |
| 8-K | 2026-06-24 | Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| PRE 14A | 2026-06-22 | Preliminary Proxy Statement |
| 8-K | 2026-06-05 | Departure/Appointment of Directors or Officers; Financial Statements and Exhibits |
| 8-K | 2026-05-15 | Results of Operations and Financial Condition; Financial Statements and Exhibits |